Minimally invasive heart valve repair in a beating heart

Abstract
In one embodiment, a method of repairing a heart valve accesses an interior of a patient's beating heart minimally invasively and inserts one or more sutures into each of a plurality of heart valve leaflets with a suturing instrument. The suture ends of the sutures are divided into suture pairs, with each pair including one suture end from a suture inserted into a first valve leaflet and one suture end from a suture inserted into a second valve leaflet. One or more tourniquet tubes is advanced over the suture pairs to the leaflets to draw the sutures together to coapt the leaflets and then the sutures are secured in that position.
Description
TECHNICAL FIELD

The present disclosure relates to minimally invasive repair of a heart valve while the patient's heart is beating. More particularly, embodiments of the present invention relate to minimally invasive systems and methods for performing an edge to edge heart valve leaflet repair on a beating heart.


BACKGROUND OF THE INVENTION

Various types of surgical procedures are currently performed to investigate, diagnose, and treat diseases of the heart and the great vessels of the thorax. Such procedures include repair and replacement of mitral, aortic, and other heart valves, repair of atrial and ventricular septal defects, pulmonary thrombectomy, treatment of aneurysms, electrophysiological mapping and ablation of the myocardium, and other procedures in which interventional devices are introduced into the interior of the heart or a great vessel.


Many of these procedures require a gross thoracotomy, usually in the form of a median sternotomy, to gain access into the patient's thoracic cavity. A saw or other cutting instrument is used to cut the sternum longitudinally, allowing two opposing halves of the anterior or ventral portion of the rib cage to be spread apart. A large opening into the thoracic cavity is thus created, through which the surgical team may directly visualize and operate upon the heart and other thoracic contents.


Surgical intervention within the heart by a thoracotomy generally requires isolation of the heart and coronary blood vessels from the remainder of the arterial system, and arrest of cardiac function (an “open heart” procedure). Usually, the heart is isolated from the arterial system by introducing an external aortic cross-clamp through a sternotomy and applying it to the aorta between the brachiocephalic artery and the coronary ostia. Cardioplegic fluid is then injected into the coronary arteries, either directly into the coronary ostia or through a puncture in the aortic root, so as to arrest cardiac function. In some cases, cardioplegic fluid is injected into the coronary sinus for retrograde perfusion of the myocardium. The patient is placed on cardiopulmonary bypass to maintain peripheral circulation of oxygenated blood.


Of particular interest are intracardiac procedures for surgical treatment of heart valves, especially the mitral and aortic valves. Tens of thousands of patients are diagnosed with aortic and mitral valve disease each year. Various surgical techniques may be used to repair a diseased or damaged valve, including annuloplasty (contracting the valve annulus), quadrangular resection (narrowing the valve leaflets), commissurotomy (cutting the valve commissures to separate the valve leaflets), shortening mitral or tricuspid valve chordae tendonae, reattachment of severed mitral or tricuspid valve chordae tendonae or papillary muscle tissue, and decalcification of valve and annulus tissue. Alternatively, the valve may be replaced by excising the valve leaflets of the natural valve and securing a replacement valve in the valve position, usually by suturing the replacement valve to the natural valve annulus. Various types of replacement valves are in current use, including mechanical and biological prostheses, homografts, and allografts. Valve replacement, however, can present a number of difficulties including that the invasiveness of the procedure can lead to long recovery times and that the irregular shape of the valve annulus can cause difficulty in properly fixing and orienting the replacement valve, which can lead to leaks and other problems. Therefore, in situations where patients can adequately be treating by repairing, rather than replacing, the valve, it is generally preferable to do so.


The mitral and tricuspid valves inside the human heart include an orifice (annulus), two (for the mitral) or three (for the tricuspid) leaflets and a subvalvular apparatus. The subvalvular apparatus includes multiple chordae tendineae, which connect the mobile valve leaflets to muscular structures (papillary muscles) inside the ventricles. Rupture or elongation of the chordae tendineae results in partial or generalized leaflet prolapse, which causes mitral (or tricuspid) valve regurgitation. A commonly used technique to surgically correct mitral valve regurgitation is the implantation of artificial chordae (usually 4-0 or 5-0 Gore-Tex sutures) between the prolapsing segment of the valve and the papillary muscle. This typically open heart operation is generally carried out through a median sternotomy and requires cardiopulmonary bypass with aortic cross-clamp and cardioplegic arrest of the heart, as described above.


Using such open heart techniques, the large opening provided by a median sternotomy or right thoracotomy enables the surgeon to see the mitral valve directly through the left atriotomy, and to position his or her hands within the thoracic cavity in close proximity to the exterior of the heart for manipulation of surgical instruments, removal of excised tissue, and/or introduction of a replacement valve through the atriotomy for attachment within the heart. However, these invasive open heart procedures produce a high degree of trauma, a significant risk of complications, an extended hospital stay, and a painful recovery period for the patient. Moreover, while heart valve surgery produces beneficial results for many patients, numerous others who might benefit from such surgery are unable or unwilling to undergo the trauma and risks of current techniques.


Techniques have been developed and are under development for minimally invasive thorascopic repair of heart valves while the heart is still beating. Int'l Pub. No. WO 2006/078694 A2 to Speziali discloses a thorascopic heart valve repair method and apparatus. Instead of requiring open heart surgery on a stopped heart, the thorascopic heart valve repair methods and apparatus taught by Speziali utilize fiber optic technology in conjunction with transesophageal echocardiography (TEE) as a visualization technique during a minimally invasive surgical procedure that can be utilized on a beating heart. U.S. Publication No. 2008/0228223 to Alkhatib also discloses an apparatus for attaching a prosthetic tether between a leaflet of a patient's heart valve and another portion of the patient's heart to help prevent prolapse of the leaflet and/or to otherwise improve leaflet function.


More recent versions of these techniques are disclosed in U.S. Patent Application Publication Nos. 2009/0105751 and 2009/0105729 to Zentgraf, which disclose an integrated device that can enter the heart chamber, navigate to the leaflet, capture the leaflet, confirm proper capture, and deliver a suture as part of a mitral valve regurgitation (MR) repair. These references are hereby incorporated by reference herein in their entirety.


An alternative to the above-described techniques that insert a suture through a single valve leaflet and anchor the suture to the heart is an edge to edge valve repair. In a traditional Alfieri edge to edge procedure, the edges of adjacent valve leaflets are sutured together to coapt the leaflets using an open surgical approach. This technique has been mimicked in minimally invasive, beating heart procedures by employing a clip that joins the leaflets together rather than a suture. U.S. Patent Publication No. 2004/0044365 to Bachman discloses a technique for minimally invasively accessing the heart through an endovascular approach to perform and edge to edge repair. After sutures are inserted into the leaflets, the sutures can be knotted external to the patient's body and advanced to the repair site with a knot-pushing device as shown, for example, in U.S. Pat. Nos. 8,202,282 and 8,075,574. However, it has been found that it can be difficult to stabilize the leaflets to maintain appropriate tension when knotting sutures in such a fashion and that it can be difficult for the knot pusher to properly advance the knot all the way to the leaflets. In addition, use of such a knot pusher risks damage to other structures within the heart. There is therefore a need for a technique for performing an edge to edge repair on a beating heart of a patient that secures the leaflets together at a proper tension in a more effective manner.


SUMMARY OF THE INVENTION

Disclosed herein are minimally invasive systems and methods for performing an edge to edge repair of a heart valve on a beating heart of a patient. One or more sutures are inserted into a plurality of leaflets of the heart valve while the heart is beating through a minimally invasive access. The sutures are secured at an appropriate tension to maintain the leaflets in a coapted position.


In one embodiment, a method of repairing a heart valve accesses an interior of a patient's beating heart minimally invasively and inserts one or more sutures into each of a plurality of heart valve leaflets with a suturing instrument. The suture ends of the sutures are divided into suture pairs, with each pair including one suture end from a suture inserted into a first valve leaflet and one suture end from a suture inserted into a second valve leaflet. One or more tourniquet tubes is advanced over the suture pairs to the leaflets to draw the sutures together to coapt the leaflets and then the sutures are secured in that position.


In one embodiment, the sutures are secured with a suture loop of a ligature assembly. The suture loop is advanced to the leaflets along the tourniquet tube(s) and tightened around the sutures to secure the position and the tourniquet tube(s) withdrawn. The sutures and ligature suture are then tied off to maintain the leaflets in an edge to edge, coapted configuration.


In another embodiment, the sutures are secured with a stabilizing tourniquet tube having a clip or suture loop positioned at its distal end. The stabilizing tourniquet tube is advanced over the sutures as described above and the sutures are secured by disconnecting a body portion of the tourniquet tube from the clip or sutures after causing the clip or sutures to be cinched around the sutures.


A system for minimally invasively repairing a heart valve in a beating heart of a patient includes a suturing instrument, a plurality of sutures, one or more tourniquet tubes, and a means for securing the sutures under tension with the leaflets in a coapted position. The suturing instrument is used to insert a plurality of sutures into the valve leaflets of the valve while the heart is beating. The one or more tourniquet tubes are used to draw the sutures together to coapt the leaflets and maintain the sutures in position so that they can be secured in that position. In various embodiments, the sutures can be secured in position with, for example, a ligature assembly, or a clip deployed by a tourniquet tube.


Various embodiments of systems, devices and methods have been described herein. These embodiments are given only by way of example and are not intended to limit the scope of the present invention. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, implantation locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the invention.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:



FIG. 1 is a schematic cross-sectional view of a heart;



FIG. 2 is a schematic top plan view of a mitral valve;



FIG. 3A is a schematic cross-sectional view of a heart with a normal mitral valve;



FIG. 3B is a partial schematic cross-sectional view of a heart with an abnormal mitral valve;



FIG. 4 is an isometric view of an instrument the can be employed with embodiments of the present invention;



FIG. 5 is a detailed isometric view of the distal end of the instrument of FIG. 4;



FIG. 6A is a detailed side elevation view of the distal end of the instrument of FIG. 4 showing the tip in a closed position;



FIG. 6B is a detailed side elevation view of the distal end of the instrument of FIG. 4 showing rods inside the instrument that are capable of sliding to move the tip to an open position;



FIG. 7 is a detailed isometric view of the distal end of the instrument of FIG. 4 showing the needle lumen and four fiberoptic channels that are disposed around the needle lumen;



FIGS. 8A-8F depict detailed isometric view of a suture being deployed into a heart valve leaflet according to embodiments of the present invention;



FIGS. 9A-9I schematically depict a method of performing an edge to edge repair of a heart valve with sutures on a beating heart of a patient according to an embodiment of the present invention;



FIGS. 10A-10D schematically depict a portion of a method of performing an edge to edge repair of a heart valve with sutures on a beating heart of a patient according to an embodiment of the present invention;



FIG. 11 schematically depicts a portion of a method of performing an edge to edge repair of a heart valve with sutures on a beating heart of a patient according to an embodiment of the present invention;



FIG. 12 is a flowchart depicting method steps or a method of performing an edge to edge repair of a heart valve with sutures on a beating heart of a patient according to embodiments of the present invention.



FIGS. 13A-13D schematically depict a portion of a method of performing an edge to edge repair of a heart valve with sutures on a beating heart of a patient according to an embodiment of the present invention;





While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications equivalents, and alternatives falling within the spirit and scope of the invention.


DETAILED DESCRIPTION

A mitral valve is schematically depicted in FIGS. 1-3B. Situated between the left atrium and left ventricle, the mitral valve consists of two flaps of tissue, or leaflets (a posterior leaflet and an anterior leaflet). The mitral valve annulus forms a ring around the valve leaflets, thereby connecting the leaflets to the heart muscle. Papillary muscles are located at the base of the left ventricle. Tendon-like cords called chordae tendineae anchor the mitral valve leaflets to the papillary muscles. Normal chordae tendineae prevent the leaflets from prolapsing, or inverting, into the left atrium, as depicted in FIG. 3A.


Under normal cardiac conditions, the left atrium contracts and forces blood through the mitral valve and into the left ventricle. As the left ventricle contracts, hemodynamic pressure forces the mitral valve shut and blood is pumped through the aortic valve into the aorta. For the mitral valve to shut properly, the valvular edges of the valve leaflets must form a non-prolapsing seal, or coaptation, that prevents the backflow of blood during left ventricular contraction.


A properly functioning mitral valve opens and closes fully. When the mitral valve fails to fully close, as depicted in FIG. 3B, blood from the left ventricle is able to flow backward into the left atrium instead of flowing forward into the aorta. This backflow of blood through the heart valve is called regurgitation. The regurgitation of blood through the heart due to the failure of the mitral valve to close properly (coapt) is the condition known as mitral valve regurgitation (MR). A common symptom of mitral valve regurgitation is congestion of blood within the lungs.


When blood regurgitates from the left ventricle into the left atrium, such as due to MR, less blood is pumped into the aorta and throughout the body. In an attempt to pump adequate blood to meet the blood needs of the body, the left ventricle tends to increase in size over time to compensate for this reduced blood flow. Ventricular enlargement, in turn, often leads to compromised contractions of the heart, thereby exacerbating the congestion of blood within the lungs. If left untreated, severe MR can eventually lead to serious cardiac arrhythmia and/or congestive heart failure (CHF).


Mitral valve regurgitation can be caused by any number of conditions, including mitral valve prolapse (a condition in which the leaflets and chordae tendineae of the mitral valve are weakened resulting in prolapse of the valve leaflets, improper closure of the mitral valve, and the backflow of blood within the heart with each contraction of the left ventricle), damaged chords (wherein the chordae tendineae become stretched or ruptured, causing substantial leakage through the mitral valve), ventricular enlargement, rheumatic fever (the infection can cause the valve leaflets to thicken, limiting the valve's ability to open, or cause scarring of the leaflets, leading to regurgitation), endocarditis (an infection inside the heart), deterioration of the mitral valve with age, prior heart attack (causing damage to the area of the heart muscle that supports the mitral valve), and a variety of congenital heart defects. As MR becomes exacerbated over time, the condition can become more severe, resulting in life-threatening complications, including atrial fibrillation (an irregular heart rhythm in which the atria beat chaotically and rapidly, causing blood clots to develop and break loose and potentially result in a stroke), heart arrhythmias, and congestive heart failure (occurring when the heart becomes unable to pump sufficient blood to meet the body's needs due to the strain on the right side of the heart caused by fluid and pressure build-up in the lungs).


The present application describes various devices and methods that can be employed on the beating heart of a patient in a minimally invasive manner to treat mitral valve regurgitation as described above. Embodiments as described herein can be used to restrain a prolapsing leaflet to prevent leaflet prolapse and to promote leaflet coaptation. According to certain embodiments, the present invention generally reduces the need to perform an edge to edge valve repair with a suture with a sternotomy and cardiopulmonary bypass surgery. Specifically, the present invention can provide a minimally invasive edge to edge treatment of MR. This treatment significantly decreases trauma to surgical patients by facilitating transapical access of a beating heart via a lateral thoracotomy in a manner that eliminates certain surgical steps normally required to complete mitral valve repair procedure by sternotomy.


In certain embodiments, the methods described herein are performed via transapical access. Transapical access to a heart includes all entry points that are within approximately the bottom third of the heart. As used in this patent application, transapical access to a heart includes all directions of entry and points of entry, as well as all angles of entry at each entry point. Further details regarding such access can be found in PCT Publication No. WO 2006/078694 to Speziali, which is hereby incorporated herein by reference in its entirety. In other embodiments, the methods can be performed via an endovascular approach, such as a transfemoral, transeptal approach. Further details regarding such an endovascular access approach can be found in U.S. Patent Publication No. 2016/014737, which is hereby incorporated by reference in its entirety.


One embodiment of an instrument 10 that can be used in performing the methods described herein is depicted in FIGS. 4 and 5. Instrument 10 includes a rigid metal shaft 100 having a handle 120 at its extrathoracic (proximal) end that enables the instrument to be manipulated and guided into position. Actuating mechanisms for controlling the grasping mechanism and needle mechanism located at the distal end 140 of the instrument are also mounted near the handle 120. The grasping mechanism is operated by squeezing the scissor-grip handle 120, and the needle mechanism is operated by moving an up-turned control shaft 122.


Located on the distal, intracardiac end 140 of the instrument 10 is a grasping mechanism which can be operated to hold a valve leaflet. As shown in FIGS. 5, 6A, 6B, and 7, in one embodiment this mechanism is a tip 160 which is supported on the distal end of the shaft 100 by a set of rods 162. The rods 162 slide within the shaft 100 to move the tip 160 between an open position as shown in FIGS. 6B and 7 and a closed position as shown in FIG. 6A when the scissor-grip handle 120 is operated. As will be explained below, a valve leaflet is located in the gap between the open tip 160 and the distal end of shaft 100 and it is captured by closing the tip 160 to pinch the valve leaflet therebetween.


Disposed in a needle lumen 164 formed in the shaft 100 is a needle 180 which connects to the control shaft 122 at the proximal end of shaft 100. Needle mechanism 180 slides between a retracted position in which it is housed in the lumen 164 near the distal end of the shaft 100 and an extended position in which it extends into the sliding tip 160 when the tip is in its closed position. As a result, if a valve leaflet has been captured between the tip 160 and the distal end of shaft 100 the needle may be extended from the lumen 164 by moving control shaft 122 to puncture the captured leaflet and pass completely through it.


The distal end of the shaft 100 can also contain an artificial chorda, or suture 18 that is to be deployed in the patient's heart. The suture 18 is typically a 4-0 or 5-0 suture manufactured by a company such as Gore-Tex. This suture 18 is deployed by the operation of the grasping mechanism and the needle mechanism 180 as described in more detail below.


The shaft 100 has a size and shape suitable to be inserted into the patient's chest and through the left ventricle cardiac wall and form a water-tight seal with the heart muscle. It has a circular or ellipsoidal cross-section and it houses the control links between the handle end and the intracardiac end of the instrument as well as a fiber optic visualization system. Further details regarding example embodiments of such devices can be found in U.S. Pat. Nos. 8,465,500; 8,758,393; and 9,192,374, each of which is hereby incorporated by reference herein in its entirety.


As shown in FIGS. 8A-8F, a suture can be deployed into a heart valve leaflet of a beating heat of a patient with instrument 10 and other similar instruments described herein. Instrument 10 is positioned around a valve leaflet 16 to be repaired as shown in FIG. 8A. In one embodiment, the suture 18 can be folded at the middle to form a loop 19 that is positioned in the tip 160. Both ends of the suture 18 can be disposed in a suture lumen 165 formed in the shaft 100 beneath the rods 162. As shown in FIG. 8B, the valve leaflet 16 is grasped by closing the tip 160, and the needle 180 is extended to puncture the leaflet 16 and extend into the tip 160. A notch 166 formed on one side of the needle 180 hooks the suture loop 19. The needle 180 is then retracted back through the leaflet 16 to pull the suture loop 19 through the puncture opening as shown in FIG. 8C. The leaflet 16 is then released and the instrument 10 is withdrawn from the heart as shown in FIG. 8D pulling both ends and the midpoint of the suture 18 with it. As shown in FIG. 8E, the suture 18 is released by the instrument 10 and the surgeon inserts the two suture ends 21 through the loop 19 at its midpoint. The ends 21 are then pulled and the loop 19 slides along the suture 18 back into the heart chamber 14 where it forms a Larks head around the edge of the valve leaflet as shown in FIG. 8F. At this point, the two free ends 21 of the suture 18 are external to the heart wall at the apex 12 of the heart. Multiple sutures 18 may be implanted in this manner.



FIGS. 9A-9I schematically depict a method of performing an edge to edge repair of a heart valve with sutures on a beating heart of a patient according to an embodiment of the present invention. Referring to FIG. 9A, in this embodiment access to the heart has been gained through the apical region 12 of the heart and a purse-string suture 13 has been placed at the access location. A plurality of sutures 18 have already been inserted into the valve leaflets using, for example, instruments and methods as described above. In the depicted embodiment, two sutures 18A have been inserted into a first leaflet 16A and two sutures 18B have been inserted into a second leaflet 16B. With respect to the mitral valve, one of the first and second valve leaflets 16A, 16B is the anterior leaflet and the other is the posterior leaflet. As described above, each suture 18A-18B forms a loop around the respective leaflet with a respective pair of free ends 21A-21B extending out of the heart. In other embodiments, different numbers of sutures could be used. For example, in one embodiment, one suture is inserted through each leaflet.


Referring to FIGS. 9B and 9C, the suture ends 21A, 21B are divided into a plurality of suture pairs 23. Each suture pair 23A-23D consists of one suture end 21A extending from the first leaflet 16A and one suture end 21B extending from the second leaflet 16B, such that each suture pair is connected to both leaflets. As can be seen in FIG. 9B, the sutures in the first suture pair 23A are threaded through a tourniquet tube 25A (e.g., a small, thin tube of plastic or similar material) and stabilized with, for example, a mosquito forceps 27A. Each of the other suture pairs 23B-23D is also threaded through a corresponding tourniquet tube 25B-25D and secured with a forceps 27B-27D. In one embodiment, each corresponding tourniquet tube and forceps, e.g., tourniquet tube 25A and forceps 27A are a common color with each other corresponding pair being a different color to enable the surgeon to easily differentiate among the pairs and to prevent potential crossing of the sutures.


Referring now to FIG. 9D, the first tourniquet tube 25A is advanced along the suture pair 23A and introduced into the heart after disengaging the mosquito forceps 27A. The tourniquet tube 25A is advanced until it reaches the leaflets. This pulls the suture ends in the suture pair 23A closer together increasing the tension thereon and drawing the leaflets 16A-16B closer together, i.e., generally into an edge to edge configuration. The mosquito forceps 27A can then again be clamped onto the tourniquet tube 25A in order to retain the relative position of the tourniquet tube 25A and suture pair 23A and the tension of the sutures to maintain the leaflets in coaptation. The same procedure is conducted with tourniquet tubes 25B-25D and suture pairs 23B-23D as shown in FIG. 9E. This draws the leaflets 16A, 16B towards coaptation at four distinct locations, corresponding to each of the suture pairs 23A-23D. At this stage, the efficacy of the procedure can be assessed using real-time transesophageal echocardiography to confirm proper valve function.


As can be seen in FIGS. 9F and 9G, a ligature assembly 31 can be used to secure the sutures 18A-18D at the required tension for coaptation of the leaflets 16A, 16B as temporarily stabilized through use of the tourniquet tubes 25A-25D and forceps 27A-27D. The ligature assembly 31 includes a tube 33 containing a suture 35 that presents a knot 39 forming a ligature loop 37 at its distal end. In one embodiment, ligature assembly is an Endoloop® PDS Ligature, available from Ethicon US, LLC. As shown in FIG. 9F, the loop 37 is positioned around all of the tourniquet tubes 25A-25D and advanced therealong towards the leaflets 16A, 16B with the plastic tube 33. Once the loop 37 has reached the leaflets 16A, 16B, it is tightened around the sutures 18A-18D via the knot 39 as shown in FIG. 9G to maintain the suture pairs 23A-23D under tension to retain the leaflets 16A, 16B in coaptation. Use of tourniquet tubes 25A-25D not only provides a more effective means for maintaining the sutures under an appropriate tension, it further protects subvalvular and other internal heart structures from damage by guiding the ligature assembly towards the leaflets and constraining the range and direction of motion the assembly can have within the heart.


The tourniquet tubes 25A-25D are then withdrawn from the sutures 18A-18D and each of the suture pairs 23A-23D and the ligature suture 35 are tied off at the access point 13 at the apex 12 of the heart as shown in FIG. 9H. The leaflets 16A, 16B are retained in an edge to edge, coapted position by the sutures 18A-18D as shown in FIG. 9I. By tying off the sutures at the apex to the heart, the sutures are aligned similarly to chordae tendinaea, and therefore provide a more natural coaptation point for the leaflet as compared to simply suturing or clipping the leaflets together.


Referring now to FIGS. 10A-10D, a method of performing an edge to edge repair of a heart valve with sutures on a beating heart of a patient according to another embodiment of the present invention is schematically depicted. The method depicted in FIGS. 10A-10D is similar in most respects to the method described above with respect to FIGS. 9A-9I. A plurality of sutures depicted as, for example, four sutures 18 are inserted into the leaflets 16A, 16B as discussed above. In this embodiment, a single tourniquet tube 25 is advanced along all four suture pairs 23 as shown in FIG. 10B. In various embodiments, tourniquet tube 25 can define a single lumen through which all suture pairs extend or can define an individual lumen within the tube for each suture pair. The procedure proceeds as described above with the loop 37 of a suture 35 of a ligature assembly 31 used to secure the sutures 18 and leaflets 16A, 16B under tension. Use of a single tourniquet tube 25 can simplify and speed up the procedure with respect to using individual tourniquet tubes 25A-25D for each suture pair 23A-23D as described above. FIG. 11 depicts a further alternative in which the entire ligature assembly 31, including the plastic tube 33 and the ligature loop 37 around the sutures 18 are advanced to the leaflets 16A-16B to secure the sutures 18 from inside of the tourniquet tube 25 rather than from the outside as previously described. Such an embodiment can provide the advantage of further protection against interference with subvalvular and other internal heart structures such as chordae tendonae due to the loop being inside the tourniquet tube and thereby precluded from contacting such structures. In a further embodiment, rather than advancing a separate ligature assembly through the inside of the tourniquet, the suture loop can be incorporated into the tourniquet itself. In one such embodiment, the inner wall of the tourniquet tube can include a channel that includes the suture loop. Once the tourniquet is in place over the sutures and against the leaflets, the suture loop can be tightened from a proximal end of the tourniquet so that it is released from a distal end of the tourniquet and secured around the sutures.


As noted above, one benefit of utilizing tourniquet tubes as described herein is to minimize interference with internal structure of the heart. To this end, tourniquet tubes are preferably provided with a minimal external form factor while still providing an opening into which sutures can be easily inserted. Individual tourniquet tubes 25A-25D can, for example, each have an outer diameter between about 2 mm to about 10 mm and an inner lumen having a diameter between about 1 mm to about 8 mm. A single tourniquet tube 25 utilized for all suture pairs can, for example, have an outer diameter between about 2 mm and about 10 mm and an inner lumen having a diameter between about 1 mm and about 8 mm. The length of any given tourniquet tube can, for example, be between about 10 mm and about 15 mm.


In a further embodiment depicted in FIGS. 13A-13D, the functions of the tourniquet tube(s) and ligature assembly described above can be incorporated into a single stabilizing tourniquet 40. After a plurality of sutures 18 are inserted into leaflets 16A, 16B as described above and depicted in FIG. 13A, the stabilizing tourniquet 40 can be advanced over the sutures. Also, as described above, after the stabilizing tourniquet 40 has been advanced to the leaflets the efficacy of the procedure can be assessed. In one embodiment, the stabilizing tourniquet 40 includes a detachable clip 42 at a distal end of the tourniquet. Once the positioning of the sutures 18 is determined to be effective, the clip 42 can be deployed from a body portion 44 of the stabilizing tourniquet 40 and cinched around the sutures 18. In one embodiment, clip 42 can be deployed by rotating body portion 44 in a first direction as depicted in FIG. 13C to tighten the clip 42 around the sutures 18 to hold the sutures 18 in the desired position. The body portion 44 can then be rotated in the opposite direction to detach the body portion 44 from the clip 42 and the body portion 44 withdrawn as shown in FIG. 13D. The clip 42 then remains in place holding the sutures and leaflets in the desired position and the procedure is concluded as described herein. In various embodiments, the clip 42 may be comprised of a same or similar plastic material as the stabilizing tourniquet or may be a different material (e.g., metal). In a further embodiment, rather than a clip 42 a suture loop may be encapsulated at the distal end of the stabilizing tourniquet such that pulling on a proximal end of the suture causes the suture to detach from the tourniquet and tighten around the sutures.



FIG. 12 depicts a flowchart of method steps for methods 200 for performing an edge to edge repair of a heart valve with sutures on a beating heart of a patient according to embodiments of the present invention. At step 202, the interior of the heart is initially accessed according to any procedure known in the art. In some embodiments, the heart is accessed via an incision in the apical region of the heart, such as through the apex of the left ventricle. In other embodiments, the heart can be accessed endovascularly, such as through the femoral vein. At step 204, one or more sutures is inserted into each of a plurality of heart valve leaflets of a heart valve, such as the mitral valve, within the heart with a suturing device such as the device described with respect to FIGS. 4-8F. In various embodiments, the device can be withdrawn after inserting each suture, reloaded with another suture and inserted into the heart to insert each subsequent suture or can be reloaded with additional sutures for insertion without being withdrawn from the heart.


The sutures are then divided into suture pairs at step 206, with each suture pair consisting of one suture end extending from a suture inserted through a first valve leaflet, such as the anterior leaflet of the mitral valve, and one suture end extending from a suture inserted through a second valve leaflet, such as the posterior leaflet of the mitral valve. One or more small tourniquet tubes can then be inserted over the sutures pairs at step 208. As described above, in various embodiments each suture pair can be provided with an individual tourniquet tube or a single tourniquet tube can be utilized for all suture pairs. A stabilizing device such as a mosquito forceps can optionally be used at step 210 to stabilize the tourniquet tube(s) on the suture pairs prior to advancing the tourniquet tube(s) along the suture pairs up to the leaflets at step 212 to draw the sutures together to coapt the leaflets. The tourniquet tube(s) and sutures can then be secured with the forceps clamping the tourniquet tube(s) and sutures in relative position to each other. Proper valve function can be confirmed using real-time transesophageal echocardiography. A ligature assembly is then advanced to the leaflets at step 214 and its suture loop tightened around the sutures to secure the sutures at the appropriate tension to maintain the leaflets in an edge to edge, coapted configuration at step 216.


As described above, in various embodiments the ligature assembly can be advanced from around the one or more tourniquet tube(s) or within a single tourniquet tube. As also described above, in various embodiments a single stabilizing tourniquet having an attached clip or suture loop can be employed in place of separate tourniquet tube(s) and ligature assembly. After the ligature suture loop (or clip) has been secured, the tourniquet tube(s) can then be withdrawn at step 218. The sutures through the leaflets and/or ligature suture are then tied off and the access point to the heart closed at step 220. The valve leaflets will therefore remain in a coapted, edge to edge position maintained by the tensioned sutures, preventing leaflet prolapse and valve regurgitation.


EXAMPLE

Transapical edge to edge mitral valve repair consistent with the above-described embodiments was performed and proven safe and efficacious in a patient with isolated P2 scallop flail/prolapse. The repair was performed to treat bileaflet commissural prolapse as a solution for a patient not considered appropriate for any other approved transcatheter repair. The patient was 72 years old and had previously had multiple left thoracotomies to treat recurrent pneumothorax presented with progressive dyspnea and New York Heart Association (NYHA) Functional Class III. Echocardiography demonstrated severe paracommissural mitral valve regurgitation. Multi-slice computed tomography demonstrated a severe calcification of the A1, P1, and P2 annular segments of the valve.


The procedure was performed under general anesthesia with standard postero-lateral ventricular access, using guidance from transesophageal echocardiography (2-D and 3-D TEE). Three sutures were implanted on the posterior leaflet (P2-P3) and three on the anterior leaflet (A2-A3). After implantation, coaptation of the two leaflets was achieved by putting tension on all of the sutures together with a tourniquet tube. Once stable coaptation was achieved, all sutures were tightened at the base of the ventricular edge of the leaflets using a ligature loop assembly (Surgitie Loop by Covidien) that was advanced over the tourniquet under echo guidance. Once the loop was secured, the tourniquet was removed, the ventricular purse string access was closed, and the sutures through the leaflets and the end of the ligature suture were fixed on the epicardium surface. The patient was discharged and at a one month follow up was asymptomatic (NYHA Functional Class I) with mild to moderate MR, confirmed by echocardiograhpic and multi-slice computed tomography.


Although specifically described with respect to the mitral valve, it should be understood the devices described herein could be used to treat any other malfunctioning valve, such as the tricuspid and aortic valves. Further, although not specifically described herein, it should be understood that the devices described in the present application could be implanted into the beating heart of the patient via various access approaches known in the art, including transapical approaches (e.g., through the apex of the left ventricle) and transvascular approaches, such as transfemorally (through the femoral vein). One example of a transapical access approach that could be employed is described in U.S. Pat. No. 9,044,221, previously incorporated by reference herein. One example of a transvascular access approach that could be employed is described in U.S. Patent Publication No. 2013/0035757, previously incorporated by reference herein. This versatility in access approach enables the access site for the procedure to be tailored to the needs of the patient.


Various embodiments of systems, devices, and methods have been described herein. These embodiments are given only by way of example and are not intended to limit the scope of the present invention. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, implantation locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the invention.

Claims
  • 1. A system for minimally invasively performing an edge to edge heart valve leaflet repair on a beating heart of a patient, comprising: a suturing device configured to grasp and stabilize each of a first valve leaflet and a second valve leaflet to minimally invasively insert one or more sutures into each of the first valve leaflet and the second valve leaflet of a heart valve in the beating heart of a patient, each suture having a pair of suture ends;a tourniquet tube configured to be advanced towards the heart valve over a plurality of suture pairs such that the sutures are drawn into a coaptation tension in which the first valve leaflet and the second valve leaflet are in a coapted position, wherein each suture pair includes one of the pair of suture ends of a suture inserted through the first valve leaflet and one of the pair of suture ends of a suture inserted through the second valve leaflet; andmeans for securing the sutures with the sutures in the coaptation tension,wherein the tourniquet tube is configured to be withdrawn from the suture ends following securement of the sutures, andwherein the suture ends are configured to be anchored at a wall of the heart with the sutures in the coaptation tension.
  • 2. The system of claim 1, wherein further comprising a ligature suture having a suture loop configured to be advanced along the tourniquet tube to the first valve leaflet and the second valve leaflet and secured around the sutures with the sutures in the coaptation tension.
  • 3. The system of claim 2, wherein the suture loop is configured to be advanced along the tourniquet tube along an exterior of the tourniquet tube.
  • 4. The system of claim 2, where the suture loop is configured to be advanced along the tourniquet tube along an interior of the tourniquet tube.
  • 5. The system of claim 1, wherein the tourniquet tube has a clip at a distal end of the tourniquet tube configured to be disconnected from a body portion of the tourniquet tube and secured around the sutures.
  • 6. The system of claim 5, wherein the body portion of the tourniquet tube is configured to be rotated in a first direction to secure the clip around the sutures and rotated in a second direction opposite of the first direction to disconnect the clip from the body portion.
  • 7. The system of claim 1, wherein the tourniquet tube is a single tourniquet tube configured to be advanced over all suture pairs.
  • 8. The system of claim 1, wherein the tourniquet tube comprises a thin plastic tube.
  • 9. A system for minimally invasively performing an edge to edge heart valve leaflet repair on a beating heart of a patient, comprising: a suturing device configured to minimally invasively insert one or more sutures into each of a first valve leaflet and a second valve leaflet of a heart valve in the beating heart of a patient, each suture having a pair of suture ends;a tourniquet tube configured to be advanced towards the heart valve over a plurality of suture pairs such that the sutures are drawn into a coaptation tension in which the first valve leaflet and the second valve leaflet are in a coapted position, wherein each suture pair includes one of the pair of suture ends of a suture inserted through the first valve leaflet and one of the pair of suture ends of a suture inserted through the second valve leaflet; andmeans for securing the sutures with the sutures in the coaptation tension,wherein the tourniquet tube is configured to be withdrawn from the suture ends following securement of the sutures, andwherein the suture ends are configured to be anchored at a wall of the heart with the sutures in the coaptation tension, andfurther comprising a plurality of tourniquet tubes including a separate tourniquet tube for each suture pair.
  • 10. A system for minimally invasively performing an edge to edge heart valve leaflet repair on a beating heart of a patient, comprising: a suturing device configured to grasp and stabilize each of a first valve leaflet and a second valve leaflet to minimally invasively insert one or more sutures into each of the first valve leaflet and the second valve leaflet of a heart valve in the beating heart of a patient, each suture having a pair of suture ends;a tourniquet tube configured to be advanced towards the heart valve into contact with the first valve leaflet and the second valve leaflet over a plurality of suture pairs such that the one or more sutures in the first valve leaflet and the one or more sutures in the second valve leaflet are drawn into a coaptation tension by the tourniquet tube in which the first valve leaflet and the second valve leaflet are in a coapted position, wherein each suture pair includes one of the pair of suture ends of a suture inserted through the first valve leaflet and one of the pair of suture ends of a suture inserted through the second valve leaflet; andwherein the tourniquet tube is configured to be withdrawn from the suture ends following securement of the sutures at the coaptation tension, andwherein the suture ends are configured to be anchored at a wall of the heart with the sutures in the coaptation tension.
  • 11. The system of claim 10, wherein further comprising a ligature suture having a suture loop configured to be advanced along the tourniquet tube to the first valve leaflet and the second valve leaflet and secured around the sutures with the sutures in the coaptation tension.
  • 12. The system of claim 11, wherein the suture loop is configured to be advanced along the tourniquet tube along an exterior of the tourniquet tube.
  • 13. The system of claim 11, where the suture loop is configured to be advanced along the tourniquet tube along an interior of the tourniquet tube.
  • 14. The system of claim 10, wherein the tourniquet tube has a clip at a distal end of the tourniquet tube configured to be disconnected from a body portion of the tourniquet tube and secured around the sutures.
  • 15. The system of claim 14, wherein the body portion of the tourniquet tube is configured to be rotated in a first direction to secure the clip around the sutures and rotated in a second direction opposite of the first direction to disconnect the clip from the body portion.
  • 16. The system of claim 10, further comprising a plurality of tourniquet tubes including a separate tourniquet tube for each suture pair.
  • 17. The system of claim 10, wherein the tourniquet tubes is a single tourniquet tube configured to be advanced over all suture pairs.
  • 18. The system of claim 10, wherein the tourniquet tube comprises a thin plastic tube.
RELATED APPLICATION

This application is a continuation of U.S. patent application Ser. No. 15/662,565 filed Jul. 28, 2017, now U.S. Pat. No. 10,213,306 issued Feb. 26, 2019, which application claims the benefit of U.S. Provisional Application No. 62/479,632 filed Mar. 31, 2017, which are hereby fully incorporated herein by reference.

US Referenced Citations (454)
Number Name Date Kind
2751908 Wallace Jun 1956 A
3664330 Deutsch May 1972 A
3664660 Runzi May 1972 A
3667474 Lapkin et al. Jun 1972 A
3744062 Parsonnet Jul 1973 A
3842840 Schweizer Oct 1974 A
4258716 Sutherland Mar 1981 A
4351345 Carney Sep 1982 A
4759348 Cawood Jul 1988 A
4836204 Landymore et al. Jun 1989 A
4935027 Yoon Jun 1990 A
4957498 Caspari et al. Sep 1990 A
4960424 Grooters Oct 1990 A
4967498 Kao Nov 1990 A
4967798 Hammer et al. Nov 1990 A
4972874 Jackson Nov 1990 A
5053013 Ensminger et al. Oct 1991 A
5059201 Asnis Oct 1991 A
5211650 Noda May 1993 A
5297536 Wilk Mar 1994 A
5304185 Taylor Apr 1994 A
5312423 Rosenbluth et al. May 1994 A
5336229 Noda Aug 1994 A
5336231 Adair Aug 1994 A
5373877 Chapman Dec 1994 A
5383877 Clarke Jan 1995 A
5431666 Sauer et al. Jul 1995 A
5433723 Lindenberg et al. Jul 1995 A
5452733 Sterman et al. Sep 1995 A
5474519 Bloomer Dec 1995 A
5537314 Kanter Jul 1996 A
5547455 McKenna et al. Aug 1996 A
5556411 Taoda et al. Sep 1996 A
5571215 Sterman et al. Nov 1996 A
5573529 Haak et al. Nov 1996 A
5601578 Murphy Feb 1997 A
5626607 Malecki et al. May 1997 A
5653716 Malo et al. Aug 1997 A
5662704 Gross Sep 1997 A
5665096 Yoon Sep 1997 A
5665100 Yoon Sep 1997 A
5667472 Finn et al. Sep 1997 A
5667473 Finn et al. Sep 1997 A
5667478 McFarlin et al. Sep 1997 A
5693091 Larson, Jr. et al. Dec 1997 A
5728113 Sherts Mar 1998 A
5741277 Gordon et al. Apr 1998 A
5762458 Wang et al. Jun 1998 A
5762613 Sutton et al. Jun 1998 A
5766163 Mueller et al. Jun 1998 A
5769791 Benaron et al. Jun 1998 A
5772597 Goldberger et al. Jun 1998 A
5772672 Toy et al. Jun 1998 A
5785658 Benaron et al. Jul 1998 A
5797960 Stevens et al. Aug 1998 A
5830231 Geiges, Jr. Nov 1998 A
5839639 Sauer et al. Nov 1998 A
5857961 Vanden Hoek et al. Jan 1999 A
5897564 Schulze et al. Apr 1999 A
5908428 Scirica et al. Jun 1999 A
5908429 Yoon Jun 1999 A
5919128 Fitch Jul 1999 A
5961440 Schweich, Jr. et al. Oct 1999 A
5972004 Williamson, IV et al. Oct 1999 A
5972030 Garrison et al. Oct 1999 A
5984939 Yoon Nov 1999 A
5993466 Yoon Nov 1999 A
5993467 Yoon Nov 1999 A
6022360 Reimels et al. Feb 2000 A
6045497 Schweich, Jr. et al. Apr 2000 A
6050936 Schweich, Jr. et al. Apr 2000 A
6053933 Balazs et al. Apr 2000 A
6059715 Schweich, Jr. et al. May 2000 A
6077214 Mortier et al. Jun 2000 A
6117144 Nobles et al. Sep 2000 A
6129683 Sutton et al. Oct 2000 A
6149660 Laufer et al. Nov 2000 A
6152934 Harper et al. Nov 2000 A
6162168 Schweich, Jr. et al. Dec 2000 A
6162233 Williamson, IV et al. Dec 2000 A
6165119 Schweich, Jr. et al. Dec 2000 A
6165120 Schweich, Jr. et al. Dec 2000 A
6165183 Kuehn et al. Dec 2000 A
6178346 Amundson et al. Jan 2001 B1
6183411 Mortier et al. Feb 2001 B1
6190357 Ferrari et al. Feb 2001 B1
6234079 Chertkow May 2001 B1
6234995 Peacock, III May 2001 B1
6245079 Nobles et al. Jun 2001 B1
6260552 Mortier et al. Jul 2001 B1
6261222 Schweich, Jr. et al. Jul 2001 B1
6264602 Mortier et al. Jul 2001 B1
6269819 Oz et al. Aug 2001 B1
6270508 Klieman et al. Aug 2001 B1
6283993 Cosgrove et al. Sep 2001 B1
6312447 Grimes Nov 2001 B1
6332863 Schweich, Jr. et al. Dec 2001 B1
6332864 Schweich, Jr. et al. Dec 2001 B1
6332893 Mortier et al. Dec 2001 B1
6355050 Andreas et al. Mar 2002 B1
6401720 Stevens et al. Jun 2002 B1
6402679 Mortier et al. Jun 2002 B1
6402680 Mortier et al. Jun 2002 B2
6402781 Landberg et al. Jun 2002 B1
6406420 McCarthy et al. Jun 2002 B1
6419626 Yoon Jul 2002 B1
6436107 Wang et al. Aug 2002 B1
6443922 Roberts et al. Sep 2002 B1
6451054 Stevens Sep 2002 B1
6461366 Seguin Oct 2002 B1
6506197 Rollero et al. Jan 2003 B1
6508777 Macoviak et al. Jan 2003 B1
6514194 Schweich, Jr. et al. Feb 2003 B2
6533796 Sauer et al. Mar 2003 B1
6537198 Vidlund et al. Mar 2003 B1
6537314 Landberg et al. Mar 2003 B2
6551331 Nobles et al. Apr 2003 B2
6558416 Cosgrove et al. May 2003 B2
6562052 Nobles et al. May 2003 B2
6564805 Garrison et al. May 2003 B2
6582388 Coleman et al. Jun 2003 B1
6585727 Cashman et al. Jul 2003 B1
6589160 Schweich, Jr. et al. Jul 2003 B2
6602288 Cosgrove et al. Aug 2003 B1
6616684 Vidlund et al. Sep 2003 B1
6619291 Hlavka et al. Sep 2003 B2
6622730 Ekvall et al. Sep 2003 B2
6626917 Craig Sep 2003 B1
6626930 Allen et al. Sep 2003 B1
6629534 Goar et al. Oct 2003 B1
6629921 Schweich, Jr. et al. Oct 2003 B1
6629984 Chan Oct 2003 B1
6645205 Ginn Nov 2003 B2
6679268 Stevens et al. Jan 2004 B2
6692605 Kerr et al. Feb 2004 B2
6695866 Kuehn et al. Feb 2004 B1
6709456 Landberg et al. Mar 2004 B2
6716224 Singhatat Apr 2004 B2
6718985 Hlavka et al. Apr 2004 B2
6723038 Schroeder et al. Apr 2004 B1
6726648 Kaplon et al. Apr 2004 B2
6733509 Nobles et al. May 2004 B2
6740107 Loeb et al. May 2004 B2
6743239 Kuehn et al. Jun 2004 B1
6746471 Mortier et al. Jun 2004 B2
6752713 Johnson, Jr. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6755777 Schweich, Jr. et al. Jun 2004 B2
6764510 Vidlund et al. Jul 2004 B2
6770083 Seguin Aug 2004 B2
6770084 Bain et al. Aug 2004 B1
6793618 Schweich, Jr. et al. Sep 2004 B2
6802860 Cosgrove et al. Oct 2004 B2
6808488 Mortier et al. Oct 2004 B2
6810882 Langberg et al. Nov 2004 B2
6840246 Downing Jan 2005 B2
6858003 Evans et al. Feb 2005 B2
6875224 Grimes Apr 2005 B2
6893448 O'Quinn et al. May 2005 B2
6896686 Weber May 2005 B2
6908424 Mortier et al. Jun 2005 B2
6918917 Nguyen et al. Jul 2005 B1
6921407 Nguyen et al. Jul 2005 B2
6929715 Fladda et al. Aug 2005 B2
6936054 Chu Aug 2005 B2
6955175 Stevens et al. Oct 2005 B2
6962605 Cosgrove et al. Nov 2005 B2
6978176 Lattouf Dec 2005 B2
6986775 Morales et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6991635 Takamoto et al. Jan 2006 B2
6997950 Chawla Feb 2006 B2
7004176 Lau Feb 2006 B2
7004952 Nobles et al. Feb 2006 B2
7011669 Kimblad Mar 2006 B2
7044905 Vidlund et al. May 2006 B2
7048754 Martin et al. May 2006 B2
7077862 Vidlund et al. Jul 2006 B2
7083628 Bachman Aug 2006 B2
7083638 Foerster Aug 2006 B2
7090686 Nobles et al. Aug 2006 B2
7094244 Schreck Aug 2006 B2
7100614 Stevens et al. Sep 2006 B2
7112207 Allen et al. Sep 2006 B2
7112219 Vidlund et al. Sep 2006 B2
7115110 Frazier et al. Oct 2006 B2
7118583 O'Quinn et al. Oct 2006 B2
7122040 Hill et al. Oct 2006 B2
7179291 Rourke et al. Feb 2007 B2
7186264 Liddicoat et al. Mar 2007 B2
7189199 McCarthy et al. Mar 2007 B2
7217240 Snow May 2007 B2
7226467 Lucatero et al. Jun 2007 B2
7247134 Vidlund et al. Jul 2007 B2
7250028 Julian et al. Jul 2007 B2
7288097 Seguin Oct 2007 B2
7294148 McCarthy Nov 2007 B2
7381210 Zarbatany et al. Jun 2008 B2
7464712 Oz et al. Dec 2008 B2
7563267 Goldfarb et al. Jul 2009 B2
7563273 Goldfarb et al. Jul 2009 B2
7604646 Goldfarb et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7635386 Gammie Dec 2009 B1
7666204 Thornton et al. Feb 2010 B2
7794474 Er et al. Sep 2010 B2
7815654 Chu Oct 2010 B2
7871433 Lattouf Jan 2011 B2
7879048 Bain et al. Feb 2011 B2
7887552 Bachman Feb 2011 B2
8052751 Aklog et al. Nov 2011 B2
8460181 Saadat et al. Jun 2013 B2
8465500 Speziali Jun 2013 B2
8469974 Skinlo et al. Jun 2013 B2
8470028 Thornton et al. Jun 2013 B2
8512362 Ewers et al. Aug 2013 B2
8523939 Hausen Sep 2013 B1
8715302 Ibrahim et al. May 2014 B2
8734505 Goldfarb et al. May 2014 B2
8758393 Zentgraf Jun 2014 B2
8795295 Sauer Aug 2014 B2
8888843 Khairkhahan et al. Nov 2014 B2
8938283 Zentgraf et al. Jan 2015 B2
8968338 Speziali Mar 2015 B2
8979750 Van Bladel et al. Mar 2015 B2
9044221 Zentgraf et al. Jun 2015 B2
9155622 Ruyra Baliarda et al. Oct 2015 B2
9192374 Zentgraf Nov 2015 B2
9198756 Aklog et al. Dec 2015 B2
9314242 Bachman Apr 2016 B2
9364213 Speziali Jun 2016 B2
9393080 Zentgraf et al. Jul 2016 B2
9468364 Malchano et al. Oct 2016 B2
9700300 Speziali Jul 2017 B2
10080659 Zentgraf et al. Sep 2018 B1
10130474 Zentgraf et al. Nov 2018 B2
10213306 Colli Feb 2019 B2
10507018 Zentgraf Dec 2019 B2
10582924 Speziali Mar 2020 B2
10588620 Caffes et al. Mar 2020 B2
10695178 Zentgraf et al. Jun 2020 B2
10765715 Kang et al. Sep 2020 B2
20010005787 Oz et al. Jun 2001 A1
20010016675 Mortier et al. Aug 2001 A1
20010021872 Bailey et al. Sep 2001 A1
20020013571 Goldfarb et al. Jan 2002 A1
20020026094 Roth Feb 2002 A1
20020029080 Mortier et al. Mar 2002 A1
20020049402 Peacock, III et al. Apr 2002 A1
20020077524 Schweich, Jr. et al. Jun 2002 A1
20020161378 Downing Oct 2002 A1
20020169359 McCarthy et al. Nov 2002 A1
20020173694 Mortier et al. Nov 2002 A1
20020183766 Seguin Dec 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20030004562 DiCarlo Jan 2003 A1
20030032979 Mortier et al. Feb 2003 A1
20030050529 Vidlund et al. Mar 2003 A1
20030050693 Quijano et al. Mar 2003 A1
20030078599 O'Quinn et al. Apr 2003 A1
20030078600 O'Quinn et al. Apr 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030120264 Lattouf Jun 2003 A1
20030120341 Shennib et al. Jun 2003 A1
20030130731 Vidlund et al. Jul 2003 A1
20030163029 Sonnenschein et al. Aug 2003 A1
20030166992 Schweich, Jr. et al. Sep 2003 A1
20030167071 Martin et al. Sep 2003 A1
20030171641 Schweich, Jr. et al. Sep 2003 A1
20030181928 Vidlund et al. Sep 2003 A1
20030187457 Weber Oct 2003 A1
20030195529 Takamoto et al. Oct 2003 A1
20030199975 Gabbay Oct 2003 A1
20040003819 St. Goar et al. Jan 2004 A1
20040030382 St. Goar et al. Feb 2004 A1
20040039442 St. Goar et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040044365 Bachman Mar 2004 A1
20040049207 Goldfarb et al. Mar 2004 A1
20040049552 Motoyama et al. Mar 2004 A1
20040087975 Lucatero et al. May 2004 A1
20040087978 Velez et al. May 2004 A1
20040092962 Thornton et al. May 2004 A1
20040097805 Verard et al. May 2004 A1
20040097979 Svanidze et al. May 2004 A1
20040116767 Lebovic et al. Jun 2004 A1
20040122448 Levine Jun 2004 A1
20040127983 Mortier et al. Jul 2004 A1
20040133063 McCarthy et al. Jul 2004 A1
20040167374 Schweich et al. Aug 2004 A1
20040167539 Kuehn et al. Aug 2004 A1
20040181238 Zarbatany et al. Sep 2004 A1
20040220593 Grennhalgh Nov 2004 A1
20040225300 Goldfarb et al. Nov 2004 A1
20040225304 Vidlund et al. Nov 2004 A1
20040236353 Bain et al. Nov 2004 A1
20040236354 Seguin Nov 2004 A1
20040236373 Anspach, III Nov 2004 A1
20040243229 Vidlund et al. Dec 2004 A1
20040267083 McCarthy et al. Dec 2004 A1
20050004665 Aklog Jan 2005 A1
20050004668 Aklog et al. Jan 2005 A1
20050021055 Toubia et al. Jan 2005 A1
20050021056 St. Goar et al. Jan 2005 A1
20050021057 St. Goar et al. Jan 2005 A1
20050033446 Deem et al. Feb 2005 A1
20050044365 Haukka et al. Feb 2005 A1
20050049667 Arbefeuille et al. Mar 2005 A1
20050065396 Mortier et al. Mar 2005 A1
20050075723 Schroeder et al. Apr 2005 A1
20050075727 Wheatley Apr 2005 A1
20050101975 Nguyen et al. May 2005 A1
20050125011 Spence et al. Jun 2005 A1
20050131277 Schweich et al. Jun 2005 A1
20050131533 Alfieri et al. Jun 2005 A1
20050143620 Mortier et al. Jun 2005 A1
20050148815 Mortier et al. Jul 2005 A1
20050149014 Hauck et al. Jul 2005 A1
20050154402 Sauer et al. Jul 2005 A1
20050165419 Sauer et al. Jul 2005 A1
20050171601 Cosgrove et al. Aug 2005 A1
20050177180 Kaganov et al. Aug 2005 A1
20050216039 Lederman Sep 2005 A1
20050222589 Chu Oct 2005 A1
20050240202 Shennib et al. Oct 2005 A1
20050251187 Beane et al. Nov 2005 A1
20060020275 Goldfarb et al. Jan 2006 A1
20060036317 Vidlund et al. Feb 2006 A1
20060041306 Vidlund et al. Feb 2006 A1
20060052868 Mortier et al. Mar 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060069304 Takemoto et al. Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060074485 Realyvasquez Apr 2006 A1
20060089671 Goldfarb et al. Apr 2006 A1
20060100699 Vidlund et al. May 2006 A1
20060127509 Eckman et al. Jun 2006 A1
20060135993 Seguin Jun 2006 A1
20060149123 Vidlund et al. Jul 2006 A1
20060161040 McCarthy et al. Jul 2006 A1
20060161193 Beane et al. Jul 2006 A1
20060184203 Martin et al. Aug 2006 A1
20060195012 Mortier et al. Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060195183 Navia et al. Aug 2006 A1
20060241340 Vidlund et al. Oct 2006 A1
20060287657 Bachman Dec 2006 A1
20070002627 Youn Jan 2007 A1
20070016288 Skis et al. Jan 2007 A1
20070027451 Desinger et al. Feb 2007 A1
20070049952 Weiss Mar 2007 A1
20070050022 Vidlund et al. Mar 2007 A1
20070055303 Vidlund et al. Mar 2007 A1
20070088375 Beane et al. Apr 2007 A1
20070093857 Rogers et al. Apr 2007 A1
20070100356 Lucatero et al. May 2007 A1
20070112244 McCarthy et al. May 2007 A1
20070112425 Schaller et al. May 2007 A1
20070118154 Crabtree May 2007 A1
20070118155 Goldfarb et al. May 2007 A1
20070118213 Loulmet May 2007 A1
20070129737 Goldfarb et al. Jun 2007 A1
20070173930 Sogard Jul 2007 A1
20070179511 Paolitto et al. Aug 2007 A1
20070197858 Goldfarb et al. Aug 2007 A1
20070203391 Bloom et al. Aug 2007 A1
20070232941 Rabinovich Oct 2007 A1
20070239272 Navia et al. Oct 2007 A1
20070244555 Rafiee et al. Oct 2007 A1
20070265643 Beane et al. Nov 2007 A1
20070299468 Viola Dec 2007 A1
20080027468 Fenton et al. Jan 2008 A1
20080051703 Thornton et al. Feb 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080065156 Hauser et al. Mar 2008 A1
20080065205 Nguyen et al. Mar 2008 A1
20080091059 Machold et al. Apr 2008 A1
20080091264 Machold et al. Apr 2008 A1
20080097482 Bain et al. Apr 2008 A1
20080097489 Goldfarb et al. Apr 2008 A1
20080109069 Coleman et al. May 2008 A1
20080125860 Webler et al. May 2008 A1
20080125861 Webler et al. May 2008 A1
20080167714 St. Goar et al. Jul 2008 A1
20080183194 Goldfarb et al. Jul 2008 A1
20080188873 Speziali Aug 2008 A1
20080195126 Solem Aug 2008 A1
20080195200 Vidlund et al. Aug 2008 A1
20080208006 Farr Aug 2008 A1
20080228223 Alkhatib Sep 2008 A1
20080228267 Spence Sep 2008 A1
20080243245 Thamber et al. Oct 2008 A1
20090062819 Burkhart et al. Mar 2009 A1
20090082857 Lashinski et al. Mar 2009 A1
20090105729 Zentgraf Apr 2009 A1
20090105751 Zentgraf Apr 2009 A1
20090131880 Speziali et al. May 2009 A1
20090131956 Dewey et al. May 2009 A1
20090156995 Martin et al. Jun 2009 A1
20090163934 Raschdorf, Jr. et al. Jun 2009 A1
20090177274 Scorsin et al. Jul 2009 A1
20090192598 Lattouf Jul 2009 A1
20090259304 O'Beirne et al. Oct 2009 A1
20090306685 Fill Dec 2009 A1
20100030061 Canfield et al. Feb 2010 A1
20100042147 Janovsky et al. Feb 2010 A1
20100160726 Windheuser et al. Jun 2010 A1
20100161047 Cabiri Jun 2010 A1
20100174297 Speziali Jul 2010 A1
20100185172 Fabro Jul 2010 A1
20100217283 St. Goar et al. Aug 2010 A1
20100234688 Carter Sep 2010 A1
20100298929 Thornton et al. Nov 2010 A1
20100331971 Keranen et al. Dec 2010 A1
20110011917 Loulmet Jan 2011 A1
20110066165 Skinlo et al. Mar 2011 A1
20110071626 Wright Mar 2011 A1
20110238088 Bolduc et al. Sep 2011 A1
20120101571 Thamber et al. Apr 2012 A1
20120157760 Aklog et al. Jun 2012 A1
20120184971 Zentgraf et al. Jul 2012 A1
20120290077 Aklog et al. Nov 2012 A1
20130035757 Zentgraf et al. Feb 2013 A1
20130072786 Keogh et al. Mar 2013 A1
20130150710 Zentgraf et al. Jun 2013 A1
20130158600 Conklin et al. Jun 2013 A1
20130231533 Papademtriou et al. Sep 2013 A1
20140018912 Delaloye et al. Jan 2014 A1
20140039324 Speziali Feb 2014 A1
20140148825 Nobles et al. May 2014 A1
20140276979 Sauer et al. Sep 2014 A1
20140364875 Zentgraf Dec 2014 A1
20150018879 Moehle Jan 2015 A1
20150134057 Rourke et al. May 2015 A1
20150148821 Speziali May 2015 A1
20150190207 Zentgraf et al. Jul 2015 A1
20150313713 Zentgraf et al. Nov 2015 A1
20150320414 Conklin Nov 2015 A1
20160143737 Zentgraf et al. May 2016 A1
20170049435 Sauer et al. Feb 2017 A1
20170290582 Speziali Oct 2017 A1
20180280138 Colli Oct 2018 A1
20180289483 Speziali et al. Oct 2018 A1
20190053902 Zentgraf et al. Feb 2019 A1
20190133766 Zentgraf et al. May 2019 A1
20190290260 Caffes et al. Sep 2019 A1
20190343626 Smirnov et al. Nov 2019 A1
20190343633 Garvin et al. Nov 2019 A1
20190343634 Garvin et al. Nov 2019 A1
20200093478 Caffes et al. Mar 2020 A1
20200121314 Speziali Apr 2020 A1
20200138430 Zentgraf May 2020 A1
20200222186 Edmiston et al. Jul 2020 A1
20200281582 Caffes et al. Sep 2020 A1
Foreign Referenced Citations (45)
Number Date Country
20 2004 01788 May 2005 DE
1039851 Jul 2005 EP
1637091 Mar 2006 EP
1845861 Oct 2007 EP
1408850 Sep 2009 EP
H04307052 Oct 1992 JP
06-142114 May 1994 JP
2004-531337 Oct 2004 JP
2007-535342 Dec 2007 JP
WO 199900059 Jan 1999 WO
WO 199930647 Jun 1999 WO
WO 200006026 Feb 2000 WO
WO 200006027 Feb 2000 WO
WO 200006028 Feb 2000 WO
WO 200016700 Mar 2000 WO
WO 200166018 Sep 2001 WO
WO 200195809 Dec 2001 WO
WO 2003001893 Jan 2003 WO
WO 2003059209 Jul 2003 WO
WO 2003079937 Oct 2003 WO
WO 2003082157 Oct 2003 WO
WO 2003082158 Oct 2003 WO
WO 2004021893 Mar 2004 WO
WO 2004043265 May 2004 WO
WO 2005039428 May 2005 WO
WO 2005087140 Sep 2005 WO
WO 2005094525 Oct 2005 WO
WO 2006012750 Feb 2006 WO
WO 2006032051 Mar 2006 WO
WO 2006065966 Jun 2006 WO
WO 2006078694 Jul 2006 WO
WO 2006116310 Nov 2006 WO
WO 2006127509 Nov 2006 WO
WO 2007002627 Jan 2007 WO
WO 2007027451 Mar 2007 WO
WO 2007062128 May 2007 WO
WO 2007081418 Jul 2007 WO
WO 2007117612 Oct 2007 WO
WO 2008010738 Jan 2008 WO
WO 2008112237 Sep 2008 WO
WO 2009052528 Apr 2009 WO
WO 2011070477 Jun 2011 WO
WO 2011137336 Nov 2011 WO
WO 2012167120 Dec 2012 WO
WO 2018183632 Oct 2018 WO
Non-Patent Literature Citations (24)
Entry
PCT Application No. PCT/US2018/025076, Search Report & Written Opinion dated Jul. 2, 2018, 19 pages.
Machine translation of JP 06142114.
Cilingiroglu et al., “Percutaneous Mitral Valve Repair with MitraClip,” Turk Kardiyoloji Dernegi arsivi, dated Mar. 2012, 2 pages.
Naqvi et al., “Beating-Heart Percutaneous Mitral Valve Repair Using a Transcatheter Endovascular Suturing Device in an Animal Model,” Official Journal of the Society for Cardiac Angiography & Interventions, Mar. 2, 2007, 3 pages.
Mitralign, “Mitral Regurgitatic, Functional Mitrial Regurgitation,” dated Dec. 6, 2016, 3 pages.
Port Access System for Mitral Valve Repair Proves Its Value in Study; MedGadget Jul. 9, 2009; available at: http://www.medgadget.com/archives/2009/07 port access system for mitral valve repair proves its value in study.html (5 pages).
Interactive Cardiovascular and Thoracic Surgery; Abstracts: Supplemental 3 to vol. 7 (Sep. 2008), 52 pages.
Application and File History for U.S. Appl. No. 15/662,565, filed Jul. 28, 2017, Inventors: Colli.
Application and File History for U.S. Appl. No. 12/254,807, filed Oct. 20, 2008, Inventors: Zentgraf.
Application and File History for U.S. Appl. No. 14/310,069, filed Jun. 20, 2014, now U.S. Pat. No. 10,507,018. Inventor: Zentgraf.
Application and File History for U.S. Appl. No. 16/678,571, filed Nov. 8, 2019. Inventor: Zentgraf.
Application and File History for U.S. Appl. No. 12/254,808, filed Oct. 20, 2008, now U.S. Pat. No. 9,192,374. Inventor: Zentgraf.
Application and File History for U.S. Appl. No. 11/813,695, filed Jul. 11, 2007, now U.S. Pat. No. 8,465,500. Inventor: Speziali.
Application and File History for U.S. Appl. No. 12/709,220, filed Feb. 19, 2010, now U.S. Pat. No. 8,968,338. Inventor: Speziali.
Application and File History for U.S. Appl. No. 13/898,709, filed May 21, 2013, now U.S. Pat. No. 9,364,213. Inventor: Speziali.
Application and File History for U.S. Appl. No. 14/614,570, filed Feb. 5, 2015, now U.S. Pat. No. 9,700,300. Inventor: Speziali.
Application and File History for U.S. Appl. No. 15/634,412, filed Jun. 27, 2017, now U.S. Pat. No. 10,582,924. Inventor: Speziali.
Application and File History for U.S. Appl. No. 16/722,604, filed Dec. 20, 2019, Inventor: Speziali.
Application and File History for U.S. Appl. No. 13/339,865, filed Dec. 29, 2011, now U.S. Pat. No. 9,044,221. Inventor: Zentgraf et al.
Application and File History for U.S. Appl. No. 13/340,185, filed Dec. 29, 2011, now U.S. Pat. No. 10,080,659. Inventor: Zentgraf et al.
Application and File History for U.S. Appl. No. 14/707,945, filed May 8, 2015, now U.S. Pat. No. 10,130,474. Inventor: Zentgraf et al.
Application and File History for U.S. Appl. No. 16/137,734, filed Sep. 21, 2018. Inventor: Zentgraf et al.
Application and File History for U.S. Appl. No. 16/191,565, filed Nov. 15, 2018. Inventor: Zentgraf et al.
EP Application No. 18775548.3, Extended European Search Report dated Apr. 30, 2021, 10 pages.
Related Publications (1)
Number Date Country
20190224012 A1 Jul 2019 US
Provisional Applications (1)
Number Date Country
62479632 Mar 2017 US
Continuations (1)
Number Date Country
Parent 15662565 Jul 2017 US
Child 16251561 US